H-1 Collagen VI myopathies: pathogenic mechanisms and novel therapeutic perspectives

Por Bonaldo, P.
Publicado em 2011

Evidence for the stochastic integration of gene trap vectors into the mouse germline.

Por Chowdhury, K, Bonaldo, P, Torres, M, Stoykova, A, Gruss, P
Publicado em 1997

Monoamine oxidase inhibition prevents mitochondrial dysfunction and apoptosis in myoblasts from patients with collagen VI myopathies

Por Sorato, E., Menazza, S., Zulian, A., Sabatelli, P., Gualandi, F., Merlini, L., Bonaldo, P., Canton, M., Bernardi, P., Di Lisa, F.
Publicado em 2014

Critical Evaluation of the Use of Cell Cultures for Inclusion in Clinical Trials of Patients Affected by Collagen VI Myopathies

Por Sabatelli, P, Palma, E, Angelin, A, Squarzoni, S, Urciuolo, A, Pellegrini, C, Tiepolo, T, Bonaldo, P, Gualandi, F, Merlini, L, Bernardi, P, Maraldi, NM
Publicado em 2012

First steps to define murine amniotic fluid stem cell microenvironment

Por Bertin, E., Piccoli, M., Franzin, C., Spiro, G., Donà, S., Dedja, A., Schiavi, F., Taschin, E., Bonaldo, P., Braghetta, P., De Coppi, P., Pozzobon, M.
Publicado no Sci Rep (2016)

The cyclophilin inhibitor Debio 025 normalizes mitochondrial function, muscle apoptosis and ultrastructural defects in Col6a1(−/−) myopathic mice

Por Tiepolo, T, Angelin, A, Palma, E, Sabatelli, P, Merlini, L, Nicolosi, L, Finetti, F, Braghetta, P, Vuagniaux, G, Dumont, J-M, Baldari, CT, Bonaldo, P, Bernardi, P
Publicado em 2009